295 related articles for article (PubMed ID: 34745848)
21. EZH2 as a new therapeutic target in brain tumors: Molecular landscape, therapeutic targeting and future prospects.
Paskeh MDA; Mehrabi A; Gholami MH; Zabolian A; Ranjbar E; Saleki H; Ranjbar A; Hashemi M; Ertas YN; Hushmandi K; Mirzaei S; Ashrafizadeh M; Zarrabi A; Samarghandian S
Biomed Pharmacother; 2022 Feb; 146():112532. PubMed ID: 34906772
[TBL] [Abstract][Full Text] [Related]
22. DNMT1 and EZH2 mediated methylation silences the microRNA-200b/a/429 gene and promotes tumor progression.
Ning X; Shi Z; Liu X; Zhang A; Han L; Jiang K; Kang C; Zhang Q
Cancer Lett; 2015 Apr; 359(2):198-205. PubMed ID: 25595591
[TBL] [Abstract][Full Text] [Related]
23. EZH2-mediated repression of GSK-3β and TP53 promotes Wnt/β-catenin signaling-dependent cell expansion in cervical carcinoma.
Chen Q; Zheng PS; Yang WT
Oncotarget; 2016 Jun; 7(24):36115-36129. PubMed ID: 27092879
[TBL] [Abstract][Full Text] [Related]
24. Immunostaining of Increased Expression of Enhancer of Zeste Homolog 2 (EZH2) in Diffuse Midline Glioma H3K27M-Mutant Patients with Poor Survival.
Karlowee V; Amatya VJ; Takayasu T; Takano M; Yonezawa U; Takeshima Y; Sugiyama K; Kurisu K; Yamasaki F
Pathobiology; 2019; 86(2-3):152-161. PubMed ID: 31096221
[TBL] [Abstract][Full Text] [Related]
25. The deletion of the protein phosphatase 1 regulator NIPP1 in testis causes hyperphosphorylation and degradation of the histone methyltransferase EZH2.
Ferreira M; Verbinnen I; Fardilha M; Van Eynde A; Bollen M
J Biol Chem; 2018 Nov; 293(47):18031-18039. PubMed ID: 30305391
[TBL] [Abstract][Full Text] [Related]
26. Phosphorylation of EZH2 activates STAT3 signaling via STAT3 methylation and promotes tumorigenicity of glioblastoma stem-like cells.
Kim E; Kim M; Woo DH; Shin Y; Shin J; Chang N; Oh YT; Kim H; Rheey J; Nakano I; Lee C; Joo KM; Rich JN; Nam DH; Lee J
Cancer Cell; 2013 Jun; 23(6):839-52. PubMed ID: 23684459
[TBL] [Abstract][Full Text] [Related]
27. Emerging Roles of LncRNAs in the EZH2-regulated Oncogenic Network.
Hao A; Wang Y; Stovall DB; Wang Y; Sui G
Int J Biol Sci; 2021; 17(13):3268-3280. PubMed ID: 34512145
[TBL] [Abstract][Full Text] [Related]
28. microRNA-124a suppresses PHF19 over-expression, EZH2 hyper-activation, and aberrant cell proliferation in human glioma.
Lu J; Ji H; Tang H; Xu Z
Biochem Biophys Res Commun; 2018 Sep; 503(3):1610-1617. PubMed ID: 30131250
[TBL] [Abstract][Full Text] [Related]
29. ZMYND8 preferentially binds phosphorylated EZH2 to promote a PRC2-dependent to -independent function switch in hypoxia-inducible factor-activated cancer.
Tang B; Sun R; Wang D; Sheng H; Wei T; Wang L; Zhang J; Ho TH; Yang L; Wei Q; Huang H
Proc Natl Acad Sci U S A; 2021 Feb; 118(8):. PubMed ID: 33593912
[TBL] [Abstract][Full Text] [Related]
30.
Lo PW; Shie JJ; Chen CH; Wu CY; Hsu TL; Wong CH
Proc Natl Acad Sci U S A; 2018 Jul; 115(28):7302-7307. PubMed ID: 29941599
[TBL] [Abstract][Full Text] [Related]
31. Histone deacetylase inhibitors deplete enhancer of zeste 2 and associated polycomb repressive complex 2 proteins in human acute leukemia cells.
Fiskus W; Pranpat M; Balasis M; Herger B; Rao R; Chinnaiyan A; Atadja P; Bhalla K
Mol Cancer Ther; 2006 Dec; 5(12):3096-104. PubMed ID: 17172412
[TBL] [Abstract][Full Text] [Related]
32. Blockade of enhancer of zeste homolog 2 alleviates renal injury associated with hyperuricemia.
Shi Y; Xu L; Tao M; Fang L; Lu J; Gu H; Ma S; Lin T; Wang Y; Bao W; Qiu A; Zhuang S; Liu N
Am J Physiol Renal Physiol; 2019 Mar; 316(3):F488-F505. PubMed ID: 30566000
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of EZH2 (Enhancer of Zeste Homolog 2) Attenuates Neuroinflammation via H3k27me3/SOCS3/TRAF6/NF-κB (Trimethylation of Histone 3 Lysine 27/Suppressor of Cytokine Signaling 3/Tumor Necrosis Factor Receptor Family 6/Nuclear Factor-κB) in a Rat Model of Subarachnoid Hemorrhage.
Luo Y; Fang Y; Kang R; Lenahan C; Gamdzyk M; Zhang Z; Okada T; Tang J; Chen S; Zhang JH
Stroke; 2020 Nov; 51(11):3320-3331. PubMed ID: 32933418
[TBL] [Abstract][Full Text] [Related]
34. Polycomb group expression signatures in the malignant progression of gliomas.
Hu Q; Wu W; Zeng A; Yu T; Shen F; Nie E; Wang Y; Liu N; Zhang J; You Y
Oncol Lett; 2017 Apr; 13(4):2583-2590. PubMed ID: 28454437
[TBL] [Abstract][Full Text] [Related]
35. Post-translational modifications of EZH2 in cancer.
Li Z; Li M; Wang D; Hou P; Chen X; Chu S; Chai D; Zheng J; Bai J
Cell Biosci; 2020 Dec; 10(1):143. PubMed ID: 33308321
[TBL] [Abstract][Full Text] [Related]
36. Epigenetic regulation of cancer biology and anti-tumor immunity by EZH2.
Christofides A; Karantanos T; Bardhan K; Boussiotis VA
Oncotarget; 2016 Dec; 7(51):85624-85640. PubMed ID: 27793053
[TBL] [Abstract][Full Text] [Related]
37. Downregulation of Ezh2 expression by RNA interference induces cell cycle arrest in the G0/G1 phase and apoptosis in U87 human glioma cells.
Zhang R; Wang R; Chang H; Wu F; Liu C; Deng D; Fan W
Oncol Rep; 2012 Dec; 28(6):2278-84. PubMed ID: 22992977
[TBL] [Abstract][Full Text] [Related]
38. Melatonin Inhibits Glioblastoma Stem-like cells through Suppression of EZH2-NOTCH1 Signaling Axis.
Zheng X; Pang B; Gu G; Gao T; Zhang R; Pang Q; Liu Q
Int J Biol Sci; 2017; 13(2):245-253. PubMed ID: 28255276
[TBL] [Abstract][Full Text] [Related]
39. O-GlcNAcylation regulates EZH2 protein stability and function.
Chu CS; Lo PW; Yeh YH; Hsu PH; Peng SH; Teng YC; Kang ML; Wong CH; Juan LJ
Proc Natl Acad Sci U S A; 2014 Jan; 111(4):1355-60. PubMed ID: 24474760
[TBL] [Abstract][Full Text] [Related]
40. BRCA1 and EZH2 cooperate in regulation of prostate cancer stem cell phenotype.
Gorodetska I; Lukiyanchuk V; Peitzsch C; Kozeretska I; Dubrovska A
Int J Cancer; 2019 Dec; 145(11):2974-2985. PubMed ID: 30968962
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
